What the company does
Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera or heat-labile toxin producing enterotoxigenic Escherichia coli bacterium; and IXCHIQ/ VLA1553, a single-dose, live-attenuated vaccine for the prevention of disease caused by chikungunya virus. The company also develops VLA15, a vaccine candidate against Borrelia, the bacterium that causes Lyme disease; S4V2, a tetravalent bioconjugate vaccine candidate …
What the weekly tape is saying
VLA closed the latest completed week at 2.29 EUR. The 4-week return is -7.6% and the 12-week return is -49.8%. Trend Signal is inactive, Market Dynamics is -1.16. Setup signature: Risk-first tape with a 12/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 3.48 EUR
- Vs Trend Line
- -34.3%
- Fair Value
- 3.76 EUR
- Vs Fair Value
- -39.3%
- 52W High
- 5.42 EUR
- 52W Low
- 2.13 EUR
- Drawdown
- -57.8%
- Range Position
- 4.6%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 26
- 52W Active Breadth
- 50.0%
- Sector Scope
- FR Healthcare
- Sector Rank
- 51 of 76
- Sector Percentile
- 33.3%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
FR Healthcare
- Tracked Peers
- 76
- 4W Rank
- 47 of 76
- Avg 1W
- -2.1%
- Avg 4W
- -5.9%
- Trend Breadth
- 28.9%
- Positive MD
- 48.7%
FR Biotechnology
- Tracked Peers
- 33
- 4W Rank
- 13 of 33
- Avg 1W
- -2.8%
- Avg 4W
- -11.9%
- Trend Breadth
- 27.3%
- Positive RS
- 21.2%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -1.16
- 4W MD Change
- -0.7%
- Relative Strength
- -38.62
- 4W RS Change
- -24.8%
- Expectation
- Negative
- Probability
- 42.96%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 2.2M
- 13W Average
- 6.3M
- 52W Average
- 5.8M
- Vs 13W
- 0.4x
- Vs 52W
- 0.4x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 11.1%
- 52W Volatility
- 10.2%
- Upside Weeks
- 24
- Downside Weeks
- 28
- Downside Breadth
- 53.8%
- Avg Gain / Loss
- 7.8% / -6.1%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- PAR
- Country
- FR
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- EUR
- Market Cap
- 488.7M
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 2.29 EUR | -2.5% | 3.48 EUR | 3.76 EUR | -1.16 | -38.62 | 2.2M | Off |
| 5 Jun 2026 | 2.34 EUR | -10.3% | 3.53 EUR | 3.79 EUR | -1.05 | -36.23 | 3.3M | Off |
| 29 May 2026 | 2.61 EUR | 5.5% | 3.58 EUR | 3.82 EUR | -1.04 | -28.83 | 4.3M | Off |
| 22 May 2026 | 2.48 EUR | 0.1% | 3.62 EUR | 3.83 EUR | -1.13 | -32.12 | 2.6M | Off |
| 15 May 2026 | 2.47 EUR | 3.0% | 3.68 EUR | 3.85 EUR | -1.15 | -30.94 | 11.6M | Off |
| 8 May 2026 | 2.40 EUR | 3.8% | 3.74 EUR | 3.87 EUR | -1.32 | -34.45 | 6.0M | Off |
| 1 May 2026 | 2.31 EUR | -0.1% | 3.81 EUR | 3.90 EUR | -1.39 | -37.06 | 3.1M | Off |
| 24 Apr 2026 | 2.31 EUR | -10.7% | 3.90 EUR | 3.92 EUR | -1.37 | -37.54 | 6.9M | Off |
| 17 Apr 2026 | 2.59 EUR | -3.1% | 3.96 EUR | 3.93 EUR | -1.16 | -32.70 | 6.1M | Off |
| 10 Apr 2026 | 2.67 EUR | -1.3% | 4.02 EUR | 3.95 EUR | -0.58 | -29.45 | 4.5M | Off |
| 3 Apr 2026 | 2.71 EUR | -1.9% | 4.06 EUR | 3.96 EUR | 0.03 | -26.06 | 5.1M | Off |
| 27 Mar 2026 | 2.76 EUR | -39.4% | 4.09 EUR | 3.98 EUR | 0.62 | -22.16 | 18.5M | Off |
| 20 Mar 2026 | 4.56 EUR | 0.3% | 4.13 EUR | 3.99 EUR | 1.07 | 28.77 | 7.2M | On |
| 13 Mar 2026 | 4.54 EUR | -0.5% | 4.14 EUR | 3.99 EUR | 1.15 | 25.29 | 7.5M | On |